Newly diagnosed with Lafora disease?
We are here to help you.
1. Learn what Lafora disease is
Start by understanding the basics. Knowing what symptoms to expect and how the condition typically progresses can help you feel more prepared to support your loved one.
👉 Read our Lafora Disease Overview
2. Talk with your care team
Your neurologist will be an important guide. They can help manage seizures, monitor other symptoms, and connect you with specialists. In addition:
-
Ask about genetic testing to confirm the exact mutation
-
Request referrals for speech, physical, or occupational therapy
-
Discuss what to expect over time
This conversation can be overwhelming, so consider bringing a list of questions and taking notes during your visit.
3. Register for research
Joining a patient registry is one of the most powerful things you can do. It not only connects you with the latest updates, it also helps scientists move research forward faster.
👉 Join the Lafora Disease Clinical Registry (Madrid)
4. Learn about treatments being studied
Although there is no cure yet, research is making exciting progress. New approaches are being explored, including:
-
Antisense oligonucleotides (ASOs) – which may target the disease at the genetic level. Learn about the ION283 Safety Study here.
-
Repurposed drugs, like Metformin – already approved for other conditions
👉 View the Lafora Disease Therapy Overview
👉 View the Lafora Therapy Clinical Pipeline
By staying informed, you’ll be ready when new options become available.
5. Connect with other families
You don’t have to do this alone. Lafora families understand exactly what you’re going through, and we are here to support you.
There are several ways to get involved:
Even a single conversation can make a world of difference.
You’re not alone
As our founder Linda Gerber said:
“Together, we can maintain hope.”
And that hope starts now! With you, your loved one, and the growing Lafora community beside you.













Elpida Therapeutics’ Press Release
/by Chelsea's HopeElpida Therapeutics released a press release about acquiring ION283 and advancing this potential therapy. We are fortunate that Terry shared a letter with us earlier in the week. For more information about the nonprofit biotech company and the license transfer from Ionis, you can read the press release that Elpida Therapeutics sent out here. Please […]